Asian Industry Groups Progress Initiatives For Faster Approvals
This article was originally published in PharmAsia News
12 research-based industry associations across Asia have held their fourth annual confab at which working group proposals on drug discovery alliances, regulations and approvals moved forward with the ultimate aim of speeding up the availability of innovative medicines their members produce.
You may also be interested in...
New potential topical therapy in dermatitis space set to move towards Japan approval submission based on positive new results.
Japan approval for BTK inhibitor marks new indication but in a small niche market, while another clearance may help extend Latuda's commercial life.
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.